Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell

Cellular Immunology

Volumn 276, Issue 1-2, 2012, Pages 122-127

  Bae, Deok Sung ^a   Hwang, Yu Kyeong ^b   Lee, Jae Kwon ^a  

^a Chungbuk National University   (South Korea)

^b Mogam Biotechnology Research Institute   (South Korea)

Author keywords

Cancer cells; Cytotoxic activity; Natural killer cells; NKG2D ligands; Quercetin

Indexed keywords

LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LIGANDS; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;

EID: 84863862799     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.04.011     Document Type: Article

References (21)

1. Li C., Ge B., Nicotra M., Stern J.N., Kopcow H.D., Chen X., Strominger J.L. JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA 2008, 105:3017-3022.
2. Furuke K., Burd P.R., Horvath-Arcidiacono J.A., Hori K., Mostowski H., Bloom E.T. Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-alpha. J. Immunol. 1999, 163:1473-1480.
3. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001, 19:197-223.
4. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
5. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001, 14:123-133.
6. Hart M.K., Kornbluth J., Main E.K., Spear B.T., Taylor J., Wilson D.B. Lymphocyte function-associated antigen 1 (LFA-1) and natural killer (NK) cell activity: LFA-1 is not necessary for all killer: target cell interactions. Cell Immunol. 1987, 109:306-317.
7. Zamai L., Ahmad M., Bennett I.M., Azzoni L., Alnemri E.S., Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 1998, 188:2375-2380.
8. Mori S., Jewett A., Murakami-Mori K., Cavalcanti M., Bonavida B. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol. Immunother. 1997, 44:282-290.
9. Zhang C., Zhang J., Niu J., Zhou Z., Tian Z. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Hum. Immunol. 2008, 69:490-500.
10. Bernstein H.B., Wang G., Plasterer M.C., Zack J.A., Ramasastry P., Mumenthaler S.M., Kitchen C.M. CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function. Virology 2009, 387:59-66.
11. Cerwenka A., Baron J.L., Lanier L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 2001, 98:11521-11526.
12. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001, 413:165-171.
13. Armeanu S., Bitzer M., Lauer U.M., Venturelli S., Pathil A., Krusch M., Kaiser S., Jobst J., Smirnow I., Wagner A., Steinle A., Salih H.R. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 2005, 65:6321-6329.
14. Davis J.M., Murphy E.A., Carmichael M.D. Effects of the dietary flavonoid quercetin upon performance and health. Curr. Sports Med. Rep. 2009, 8:206-213.
15. Bae J.H., Kim J.Y., Kim M.J., Chang S.H., Park Y.S., Son C.H., Park S.J., Chung J.S., Lee E.Y., Kim S.H., Kang C.D. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. J. Immunother. 2010, 33:391-401.
16. Schwinn N., Vokhminova D., Sucker A., Textor S., Striegel S., Moll I., Nausch N., Tuettenberg J., Steinle A., Cerwenka A., Schadendorf D., Paschen A. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Int. J. Cancer 2009, 124:1594-1604.
17. Nedvetzki S., Sowinski S., Eagle R.A., Harris J., Vely F., Pende D., Trowsdale J., Vivier E., Gordon S., Davis D.M. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 2007, 109:3776-3785.
18. Schrama D., Terheyden P., Otto K., Kammerer U., Brocker E.B., Luhder F., Cosman D., Andersen M.H., Becker J.C. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells. Eur. J. Immunol. 2006, 36:65-72.
19. Ebihara T., Masuda H., Akazawa T., Shingai M., Kikuta H., Ariga T., Matsumoto M., Seya T. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int. Immunol. 2007, 19:1145-1155.
20. Rabinovich B.A., Li J., Shannon J., Hurren R., Chalupny J., Cosman D., Miller R.G. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 2003, 170:3572-3576.
21. Cerboni C., Zingoni A., Cippitelli M., Piccoli M., Frati L., Santoni A. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood 2007, 110:606-615.